Clinical Trials Emerging Market in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials Emerging Market in Colombia

Clinical Trials Emerging Market in Colombia – Clinical Trials in LATAM

In the realm of medical research, clinical trials are the cornerstone of innovation and progress. These trials play a pivotal role in testing the safety and efficacy of new drugs, therapies, and medical interventions. While established markets have long been the focus of clinical trials, emerging markets are now gaining traction as promising destinations for this vital research.

Among them, Colombia shines as a beacon of opportunity, offering a conducive environment for conducting clinical trials. In this blog, we will delve into the emerging market of clinical trials in Colombia, exploring its advantages, potential contributions to healthcare, challenges, and the role it plays in shaping global medical advancements.

Advantages of Conducting Clinical Trials in Colombia

  1. Diverse and Representative Patient Pool: Colombia’s population encompasses a rich mix of ethnicities and genetic backgrounds, providing a diverse patient pool for clinical trials. This diversity is invaluable for generating comprehensive data that can be extrapolated to broader global populations, enhancing the reliability of trial outcomes.
  2. Efficient Patient Recruitment: The country’s large and readily accessible patient population can expedite the recruitment process, reducing the time required for trials. Swift recruitment is particularly critical for time-sensitive studies and contributes to accelerated research progress.
  3. Cost-Effectiveness: Conducting clinical trials in Colombia is often more cost-effective compared to established markets. Lower operational costs, reduced expenses for labor and infrastructure, and favorable currency exchange rates make it an attractive option for pharmaceutical and biotechnology companies seeking cost savings.
  4. Skilled Healthcare Professionals: Colombia boasts a robust network of highly trained healthcare professionals and researchers. Collaborating with these experts enhances the quality of clinical trial execution and contributes to the generation of reliable data.
  5. Supportive Regulatory Environment: Colombia’s regulatory framework for clinical trials has evolved to facilitate efficient trial initiation and execution. Regulatory authorities are committed to streamlining processes while ensuring participant safety and ethical standards.

Clinical Trials Emerging Market in Colombia

Clinical Trials Emerging Market in Colombia

Clinical Trials Emerging Market in Colombia

Challenges and Considerations

  1. Infrastructure Variability: While Colombia’s urban centers boast advanced healthcare infrastructure, some remote or rural areas may lack the necessary facilities for conducting clinical trials. Site selection becomes crucial to ensure adequate resources.
  2. Language and Cultural Sensitivity: Effective communication with participants is essential for successful trials. Addressing language barriers and cultural considerations is imperative to ensure participants fully understand the trial procedures and requirements.
  3. Data Quality and Compliance: Ensuring data accuracy, integrity, and compliance with international standards are paramount. Sponsors must collaborate closely with trial sites to implement robust data collection and monitoring practices.
  4. Intellectual Property Protection: Navigating intellectual property rights and data protection regulations is crucial to safeguard proprietary information. A clear understanding of local laws and regulations is essential for protecting sponsors’ interests.
  5. Ethical and Social Factors: Respecting ethical guidelines and obtaining informed consent from participants is a fundamental ethical consideration. Sponsors must navigate cultural norms and societal perceptions to uphold the highest ethical standards.

Impact on Global Healthcare Landscape

Colombia’s emergence as an emerging market for clinical trials holds significant implications for global healthcare advancement. The data generated from trials conducted in Colombia contributes to a more comprehensive understanding of medical treatments, especially their effects on diverse populations. This knowledge can lead to more tailored and effective healthcare interventions that benefit individuals across the world.

Furthermore, the rise of clinical trials in Colombia fosters collaboration between local researchers, international pharmaceutical companies, and academic institutions. This exchange of expertise accelerates medical progress and supports the development of innovative therapies for a wide array of diseases.


Colombia’s ascendancy as an emerging market for clinical trials underscores its potential to drive medical research and healthcare innovation. With its diverse patient pool, cost advantages, regulatory improvements, and a skilled healthcare workforce, Colombia presents an enticing environment for conducting clinical trials. While challenges related to infrastructure, language, and ethical considerations persist, the opportunities far outweigh the obstacles.

As the global healthcare landscape evolves, Colombia’s contributions to clinical research hold the promise of breakthrough discoveries, enhanced patient outcomes, and a more inclusive comprehension of medical treatments.

Pharmaceutical and biotech companies can harness not only the cost efficiencies of conducting trials in Colombia but also the valuable insights gained through collaboration with the country’s scientific community. Together, we can embrace the transformative potential of Colombia’s clinical trials emerging market and shape a healthier future for all.

Clinical Trials Emerging Market in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials Emerging Market in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials Emerging Market in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials Emerging Market in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials Emerging Market in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials Emerging Market in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials Emerging Market in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials Emerging Market in Colombia

The Cohortias Team

Clinical Trials Emerging Market in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials Emerging Market in Colombia

Network & Partnerships